JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 83 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,438,000 | -15.1% | 375,000 | 0.0% | 0.30% | -26.4% |
| Q2 2018 | $2,873,000 | -79.8% | 375,000 | -40.9% | 0.40% | -83.9% |
| Q1 2018 | $14,192,000 | +134.3% | 635,000 | +33.7% | 2.50% | +69.2% |
| Q4 2017 | $6,056,000 | -2.8% | 475,000 | +18.8% | 1.48% | -16.1% |
| Q3 2017 | $6,229,000 | +177.5% | 399,825 | +149.9% | 1.76% | +111.9% |
| Q2 2017 | $2,245,000 | -21.5% | 160,000 | +23.1% | 0.83% | -50.8% |
| Q1 2017 | $2,859,000 | – | 130,000 | – | 1.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $4,084,000 | 88.46% |
| Ally Bridge Group (NY) LLC | 550,000 | $1,667,000 | 1.52% |
| TRV GP III, LLC | 1,148,780 | $3,481,000 | 1.42% |
| Deep Track Capital, LP | 4,259,653 | $12,907,000 | 0.85% |
| COWEN AND COMPANY, LLC | 2,843,149 | $8,615,000 | 0.83% |
| PFM Health Sciences, LP | 3,949,668 | $11,967,000 | 0.46% |
| RTW INVESTMENTS, LP | 4,358,433 | $13,206,000 | 0.34% |
| Omega Fund Management, LLC | 275,513 | $835,000 | 0.27% |
| Sofinnova Investments, Inc. | 981,928 | $2,975,000 | 0.25% |
| Orbimed Advisors | 2,928,900 | $8,875,000 | 0.16% |